Intelligent Bio Solutions (NASDAQ:INBS – Get Free Report) last posted its quarterly earnings data on Thursday, November 7th. The company reported ($0.70) EPS for the quarter, missing the ...

On Tuesday, Intelligent Bio Solutions Inc. (NASDAQ:INBS) announced a partnership with IVY Diagnostics Srl to strengthen its presence in Europe and the Middle East. IVY Diagnostics serves as Intell ...

NEW YORK, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering ...

If you would like to submit a Review to the journal, we would encourage you to complete the following review proposal form and return it by email to [email protected] before submission. This will ...

NEW YORK, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering ...

There are no submission charges for Materials Advances. *15% RSC member and R&P Institution discount available. Applicable to full price only. Use our journal finder to check if your APC is covered by ...

Intelligent Bio Solutions (INBS) announced the strengthening of its foothold throughout Europe and the Middle East through its partnership with IVY Diagnostics Srl. As a key distributor ...

NEW YORK, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing ...

Chief Executive Tom Polen said he believes the separation would help differentiate BD in the medical-technology industry, and ...